CTOs on the Move

Meridian Heights Afc

www.hiawathabehavioral.org

 
Meridian Heights Afc is a Sault Sainte Marie, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

StoneRidge Treatment & Recovery

StoneRidge Treatment & Recovery is a leading addiction treatment center located in Prescott Valley. We specialize in providing world-class brain-focused mental health and addiction services. Our comprehensive approach includes addiction detox services,...

Essen Health Care

essen Health Care is a healthcare continuum in New York with over 300 providers across Manhattan, Bronx, Queens, Staten Island, Long Island and Westchester County. Essen is a patient focused integrated healthcare delivery platform with the goal of prov...

Excerpta Medica

Excerpta Medica is a Bridgewater, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

The Fertility Partners

Founded in March 2019, the objective of The Fertility Partners (“TFP”) is to be a world class business partner of choice for leading North-American IVF clinicians with the goal of achieving global best clinical outcomes, an international reputation for excellence and exceptional patient experiences. TFP will provide partner clinics with back office support and a collaborative synergistic medical-scientific, professional and business environment.

CASI Pharmaceuticals

CASI Pharmaceuticals, Inc. (NASDAQ:CASI) is a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a primary focus on China. Our mission is to become an integrated biopharmaceutical company with significant market share in China, while establishing partnerships for global development and commercialization. Part of our strategy is to leverage our expertise and resources in North America and China to bring safer, more effective, and/or easier-to-use drugs to patients and to develop them more cost-effectively and faster using our unique dual development approach.